H. Wilde, T. Hemachudha, and A. Jackson, Viewpoint: management of human rabies, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.102, issue.10, pp.979-82, 2008.
DOI : 10.1016/j.trstmh.2008.04.008

URL : http://trstmh.oxfordjournals.org/cgi/content/short/102/10/979

S. Manning, C. Rupprecht, D. Fishbein, C. Hanlon, B. Lumlertdacha et al., Human rabies prevention?United States, 2008: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control, vol.57, pp.1-28, 2008.

D. Veritas, Interpretation of Rabies Risk Assessment: Final Report Report for Defra (UK) 2011

A. Goddard, N. Donaldson, D. Horton, R. Kosmider, L. Kelly et al., A Quantitative Release Assessment for the Noncommercial Movement of Companion Animals: Risk of Rabies Reintroduction to the United Kingdom, Risk Analysis, vol.165, issue.13, pp.1769-83, 2012.
DOI : 10.1111/j.1539-6924.2012.01804.x

F. Ribadeau-dumas, L. Dacheux, and H. Bourhy, La rage, m??decine/sciences, vol.29, issue.1, pp.47-55, 2013.
DOI : 10.1051/medsci/2013291013

URL : https://hal.archives-ouvertes.fr/pasteur-01481635

D. Robinson, Dog bites and rabies: an assessment of risk., BMJ, vol.1, issue.6017, p.1066, 1976.
DOI : 10.1136/bmj.1.6017.1066

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1639881

C. Rupprecht and R. Gibbons, Prophylaxis against Rabies, New England Journal of Medicine, vol.351, issue.25, pp.2626-2661, 2004.
DOI : 10.1056/NEJMcp042140

G. Serres, D. Skowronski, P. Mimault, M. Ouakki, R. Maranda-aubut et al., Bats in the Bedroom, Bats in the Belfry: Reanalysis of the Rationale for Rabies Postexposure Prophylaxis, Clinical Infectious Diseases, vol.48, issue.11, pp.1493-1502, 2009.
DOI : 10.1086/598998

A. Gunther, G. Burchard, and C. Schoenfeld, Rabies vaccination and traffic accidents, Travel Medicine and Infectious Disease, vol.6, issue.5, pp.326-333, 2008.
DOI : 10.1016/j.tmaid.2008.05.003

L. Dacheux, F. Larrous, A. Mailles, D. Boisseleau, O. Delmas et al., European Bat Lyssavirus Transmission among Cats, Europe, Emerging Infectious Diseases, vol.15, issue.2, pp.280-284, 2009.
DOI : 10.3201/eid1502.080637

URL : http://doi.org/10.3201/eid1502.080637

E. Picard-meyer, A. Servat, E. Robardet, M. Moinet, C. Borel et al., Isolation of Bokeloh bat lyssavirus in Myotis nattereri in France, Archives of Virology, vol.43, issue.11, pp.2333-2373, 2013.
DOI : 10.1007/s00705-013-1747-y

Y. Rotivel, M. Goudal, and A. Simons-de-fanti, Human rabies prophylactics: the French experience, Vaccine, vol.21, issue.7-8, pp.710-715, 2003.
DOI : 10.1016/S0264-410X(02)00586-8

C. Rupprecht, D. Briggs, C. Brown, R. Franka, S. Katz et al., Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices, MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control, vol.59, pp.1-9, 2010.

F. Ribadeau-dumas, L. Dacheux, and H. Bourhy, Epidemiology of post-exposure prophylaxis against rabies in France Fr Rabies Natl Ref Cent 2012, Annual Report, 2011.

D. Shepard, . In, M. Gold, J. Siegel, L. Russell et al., Cost-effectiveness in Health and Medicine. By M.R. Gold, J.E Siegel, L.B. Russell, and M.C. Weinstein (eds). New York: Oxford University Press, 1996, Costeffectiveness in health and medicine, pp.91-93, 1996.
DOI : 10.1002/(SICI)1099-176X(199906)2:2<91::AID-MHP46>3.0.CO;2-I

M. Warrell, Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure, Travel Medicine and Infectious Disease, vol.10, issue.1, pp.1-15, 2012.
DOI : 10.1016/j.tmaid.2011.12.005

W. Haupt, Rabies ??? risk of exposure and current trends in prevention of human cases, Vaccine, vol.17, issue.13-14, pp.1742-1751, 1999.
DOI : 10.1016/S0264-410X(98)00447-2

H. Lafeuille, Recommandations relatives à la vaccination antirabique préventive au traitement post-exposition et au suivi sérologique des personnes régulièrement exposées aux virus de la rage des chauvessouris en France métropolitaine. Cons Supér Hygiène Publique Fr, 2005.

F. Mattner, F. Bitz, M. Goedecke, A. Viertel, S. Kuhn et al., Adverse Effects of Rabies Pre- and Postexposure Prophylaxis in 290 Health-Care-Workers Exposed to a Rabies Infected Organ Donor or Transplant Recipients, Infection, vol.16, issue.4, pp.219-243, 2007.
DOI : 10.1007/s15010-007-6277-7

T. Sari, N. Tulek, C. Bulut, B. Oral, T. Ertem et al., Adverse events following rabies post-exposure prophylaxis: A comparative study of two different schedules and two vaccines, Travel Medicine and Infectious Disease, vol.12, issue.6, pp.659-66, 2014.
DOI : 10.1016/j.tmaid.2014.03.004

A. Technique, Information sur l'Hospitalisation (ATIH) Référentiel de coûts MCO 2010

S. Kreindel, M. Mcguill, M. Meltzer, C. Rupprecht, D. Jr et al., The cost of rabies postexposure prophylaxis: one state's experience. Public Health Rep Wash DC, pp.247-51, 19741998.

T. Dhand, N. Gyeltshen, T. Firestone, S. Zangmo, C. Dema et al., Dog Bites in humans and estimating human rabies mortality in rabies endemic areas of Bhutan, PLoS Negl Trop Dis, vol.5, p.1391, 2011.

M. Baltazard and M. Ghodssi, Prevention of human rabies, Bull World Health Organ, vol.10, pp.797-803, 1954.

M. Hattwick, R. Rubin, S. Music, R. Sikes, J. Smith et al., Postexposure Rabies Prophylaxis With Human Rabies Immune Globulin, JAMA: The Journal of the American Medical Association, vol.227, issue.4, pp.407-417, 1974.
DOI : 10.1001/jama.1974.03230170023005

N. Veeraraghavan, Phenolized vaccine treatment of people exposed to rabies in Southern India, Bull World Health Organ, vol.10, pp.789-96, 1954.

K. Meyer, Can man be protected against rabies?, Bull World Health Organ, vol.10, pp.845-66, 1954.

M. Nikolic, The results of rabies vaccination of man after wolf bite, Z Für Tropenmedizin Parasitol, vol.3, pp.283-96, 1952.

F. Ribadeau-dumas, L. Dacheux, and H. Bourhy, Eradication de la rage et risque résiduel en France métropolitaine, Med Mal Infect, vol.42, p.24, 2012.

C. Mathers, T. Vos, A. Lopez, J. Salomon, and M. Ezzati, National burden of diseases studies: a practical guide. Edition 2.0 Geneva: WHO Global Program on Evidence for Health Policy, 2001.

K. Hampson, S. Cleaveland, and D. Briggs, Evaluation of Cost-Effective Strategies for Rabies Post-Exposure Vaccination in Low-Income Countries, PLoS Neglected Tropical Diseases, vol.10, issue.50, p.982, 2011.
DOI : 10.1371/journal.pntd.0000982.s001

P. Dhankhar, S. Vaidya, D. Fishbien, and M. Meltzer, Cost effectiveness of rabies post exposure prophylaxis in the United States, Vaccine, vol.26, issue.33, pp.4251-4256, 2008.
DOI : 10.1016/j.vaccine.2008.05.048

E. Shim, K. Hampson, S. Cleaveland, and A. Galvani, Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania, Vaccine, vol.27, issue.51, pp.7167-72, 2009.
DOI : 10.1016/j.vaccine.2009.09.027

P. Chulasugandha, P. Khawplod, P. Havanond, and H. Wilde, Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children, Vaccine, vol.24, issue.9, pp.1478-82, 2006.
DOI : 10.1016/j.vaccine.2005.03.059

N. Hatam, F. Esmaelzade, A. Mirahmadizadeh, K. Keshavarz, A. Rajabi et al., Cost-effectiveness of rabies post exposure prophylaxis in Iran, J Res Health Sci, vol.14, pp.122-129, 2013.

D. Redelmeier and B. Mclellan, Modern medicine is neglect- ing road traffic crashes, PLoS Med, vol.10, 2013.
DOI : 10.1371/journal.pmed.1001463

URL : http://doi.org/10.1371/journal.pmed.1001463

L. Orriols, B. Delorme, B. Gadegbeku, A. Tricotel, B. Contrand et al., Prescription Medicines and the Risk of Road Traffic Crashes: A French Registry-Based Study, PLoS Medicine, vol.30, issue.11, p.1000366, 2010.
DOI : 10.1371/journal.pmed.1000366.t007

URL : https://hal.archives-ouvertes.fr/inserm-00700891

Z. Gong, F. He, and Z. Chen, Risk Factors for Human Rabies in China, Zoonoses and Public Health, vol.23, issue.1, pp.39-43, 2012.
DOI : 10.1111/j.1863-2378.2011.01416.x